Real-world LDL-C goal attainment among Taiwanese ASCVD patients is low, underscoring the need for intensified lipid management and improved adherence to guideline-based therapy. Tailored interventions are especially warranted for non-CAD ASCVD patients to reduce cardiovascular risk.
Chen et al. (Sun,) studied this question.